HeartSciences Statistics Share Statistics HeartSciences has 2.24M
shares outstanding. The number of shares has increased by 128.93%
in one year.
Shares Outstanding 2.24M Shares Change (YoY) 128.93% Shares Change (QoQ) 107.62% Owned by Institutions (%) 2.89% Shares Floating 2.03M Failed to Deliver (FTD) Shares 1 FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 109.23K, so 4.13% of the outstanding
shares have been sold short.
Short Interest 109.23K Short % of Shares Out 4.13% Short % of Float 4.3% Short Ratio (days to cover) 1.33
Valuation Ratios The PE ratio is -0.38 and the forward
PE ratio is -0.5.
HeartSciences's PEG ratio is
0.01.
PE Ratio -0.38 Forward PE -0.5 PS Ratio 757.08 Forward PS 166.1 PB Ratio 16.05 P/FCF Ratio -0.44 PEG Ratio 0.01
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for HeartSciences.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 0.59,
with a Debt / Equity ratio of 14.55.
Current Ratio 0.59 Quick Ratio 0.41 Debt / Equity 14.55 Debt / EBITDA -0.37 Debt / FCF -0.4 Interest Coverage -16.69
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $290 Profits Per Employee $-584.35K Employee Count 15 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -14.75% in the
last 52 weeks. The beta is 2.59, so HeartSciences's
price volatility has been higher than the market average.
Beta 2.59 52-Week Price Change -14.75% 50-Day Moving Average 3.49 200-Day Moving Average 3.51 Relative Strength Index (RSI) 56.13 Average Volume (20 Days) 131,906
Income Statement In the last 12 months, HeartSciences had revenue of 4.35K
and earned -8.77M
in profits. Earnings per share was -9.34.
Revenue 4.35K Gross Profit 2.47K Operating Income -8.35M Net Income -8.77M EBITDA -8.14M EBIT -8.26M Earnings Per Share (EPS) -9.34
Full Income Statement Balance Sheet The company has 1.1M in cash and 2.99M in
debt, giving a net cash position of -1.89M.
Cash & Cash Equivalents 1.1M Total Debt 2.99M Net Cash -1.89M Retained Earnings -76.13M Total Assets 6.44B Working Capital 4.41B
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -7.41M
and capital expenditures -30.19K, giving a free cash flow of -7.44M.
Operating Cash Flow -7.41M Capital Expenditures -30.19K Free Cash Flow -7.44M FCF Per Share -7.93
Full Cash Flow Statement Margins Gross margin is 56.78%, with operating and profit margins of -192013.13% and -201499.52%.
Gross Margin 56.78% Operating Margin -192013.13% Pretax Margin -201499.52% Profit Margin -201499.52% EBITDA Margin -187053.33% EBIT Margin -192013.13% FCF Margin -171107.63%
Dividends & Yields HSCS does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for HSCS is $10.5,
which is 183.8% higher than the current price. The consensus rating is "Buy".
Price Target $10.5 Price Target Difference 183.8% Analyst Consensus Buy Analyst Count 2
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on May 17, 2024. It was a
backward
split with a ratio of 1:100.
Last Split Date May 17, 2024 Split Type backward Split Ratio 1:100
Scores Altman Z-Score 2.29 Piotroski F-Score 3
